This page shows the latest Aplidin news and features for those working in and with pharma, biotech and healthcare.
abaloparatide) and confirming its earlier rejection of Pharma Mar’s Aplidin (plitidepsin) as a treatment for multiple myeloma.
Other anti-cancer agents. Plitidepsin (Aplidin; PharmaMar) induces cell death through various cellular pathways.
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
We love what we do and we think it shows.It shows in the work we do, the space we work...